Showing results (261-270 of 300) with videos related to

Sort By:
Pageof 30
Proceedings of the National Academy of Sciences of the United States of America|November 12, 1996
Induction of cyclin D1 by simian virus 40 small tumor antigenG Watanabe, A Howe, R J Lee, et al.
The American Journal of Cardiology|April 15, 1997
Risk of thromboembolism in chronic atrial flutterK A Wood, S J Eisenberg, J M Kalman, et al.
BMJ Open|January 24, 2016
Patient characteristics associated with risk of first hospital admission and readmission for acute exacerbation of chronic obstructive pulmonary disease (COPD) following primary care COPD diagnosis: a cohort study using linked electronic patient recordsL C Hunter, R J Lee, I Butcher, et al.
Circulation|November 15, 1995
Radiofrequency catheter modification of the sinus node for "inappropriate" sinus tachycardiaR J Lee, J M Kalman, A P Fitzpatrick, et al.
Circulation|April 1, 1991
Oral administration of DuP 753, a specific angiotensin II receptor antagonist, to normal male volunteers. Inhibition of pressor response to exogenous angiotensin I and IIY Christen, B Waeber, J Nussberger, et al.
Human Reproduction (Oxford, England)|February 21, 2012
Physiological sex steroid replacement in premature ovarian failure: randomized crossover trial of effect on uterine volume, endometrial thickness and blood flow, compared with a standard regimenR L O'Donnell, P Warner, R J Lee, et al.
Cell Death & Disease|February 12, 2026
RIPK1 regulates β-cell fate via actions on gene expression and kinase signaling in a mouse model of β-cell self-reactivityChristopher J Contreras, Noyonika Mukherjee, Arianna Harris-Kawano, et al.
Regulatory Toxicology and Pharmacology : RTP|July 11, 2015
How reliable are crystalline silica dust concentration measurements?L A Cox, D R Van Orden, R J Lee, et al.
American Heart Journal|November 1, 1996
Long-term results of electrophysiologically guided sotalol therapy for life-threatening ventricular arrhythmiasR J Lee, M Wong, A Siu, et al.
European Journal of Cancer (Oxford, England : 1990)|November 28, 2017
Plasma total cell-free DNA (cfDNA) is a surrogate biomarker for tumour burden and a prognostic biomarker for survival in metastatic melanoma patientsS Valpione, G Gremel, P Mundra, et al.
Pageof 30